Clinical Trials Browser

Multiple Myeloma × tanespimycin × Clear all

NCT00514371 2015-12-07

TIME-2

Phase 2/3 Completed

Multiple Myeloma

NCT00303797 2013-03-19

Sorafenib and Bortezomib in Treating Patients With Advanced Cancer

Phase 1 Completed

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00546780 2011-06-28

BMS TIME-1

Phase 3 Completed

Multiple Myeloma

NCT00113204 2008-05-20

IPi-504-01

Phase 1 Completed

Other hematologic neoplasmPlasma cell

Hematologic Diseases, Multiple Myeloma, Recurrence, Hematologic Neoplasms